Download PDF
Thromb Haemost 1974; 32(01): 065-070
DOI: 10.1055/s-0038-1647673
Original Article
Schattauer GmbH

Fibrinolytic Activity at High Altitude and Sodium Acetate Buffer

I. S Chohan   *
1   Coagulation Laboratory, Army Hospital, Delhi-Cant. India
,
I Singh
1   Coagulation Laboratory, Army Hospital, Delhi-Cant. India
,
K Balakrihsnan
1   Coagulation Laboratory, Army Hospital, Delhi-Cant. India
› Author Affiliations
Further Information

Publication History

Received for publication 04 March 1974

Accepted for publication 13 May 1974

Publication Date:
30 June 2018 (online)

    Permissions and Reprints

Summary

At high altitude there is a tendency for fibrinolytic activity to be enhanced depending, perhaps, on the duration of exposure and this seems to be a protective mechanism against the development of high altitude pulmonary oedema which is associated with diminished fibrinolytic activity. The fibrinolytic response at high altitude seems to be fluctuated during the process of acclimatisation though being maintained at a plateau higher than that in the plains. It apparently results from hypoxic stress but more likely reflects the physiological response to the hypercoagulable state at high altitude. As clot lysis times in high altitude pulmonary oedema are unusually prolonged an attempt at shortening their observation in the test system is desirable. Sodium acetate, 0.12 M solution with pH 7.4 as a diluent in the low temperature technique of dilute clot lysis time is potentially effective to accelerate the lysis time by approximately 33 % compared to phosphate buffer solution of similar pH and molarity. Also the end point of disintegration of clot is more abrupt and sharply defined. Sodium acetate buffer can advantageously replace phosphate buffer as a diluent in this technique.

* Present address: Bloedstolling Laboratorium (Dir. Prof. M. Verstraete), Academisch Ziekenhuis, Sint Rafaꪬ 3000 Leuven (Belgium) on leave of absence from the Directorate General Armed Forces Medical Services, New Delhi-1, INDIA


 

  • References

  • 1 Chohan I. S, Balakrishnan K, Talwar G. P. 1971; Electrophoretic mobility of platelets in high altitude pulmonary oedema and high altitude pulmonary hypertension and immunoglobulins levels at high altitude. Armed Forces Medical Journal (India) 27: 437.
    PubMedGoogle Scholar
  • 2 Chohaist I. S. 1971. Fibrinolytic activity, platelet functions and immune response at high altitude. Thesis for M. D. All India Institute of Medical Sciences. New Delhi.:
    Google Scholar
  • 3 Dalby A, Mertz E. T. 1957; Effect of chloride and other ions on the activation of bovine plasminogen (profibrinolysin). American Journal of Physiology 191: 505.
    PubMedGoogle Scholar
  • 4 Fearnley G. R. 1960; Spontaneous Fibrinolysis. The American Journal of Cardiology 06: 371.
    CrossrefPubMedGoogle Scholar
  • 5 Fearnley G. R, Balmforth G. V, Fearnley E. 1957; Evidence of a diurnal fibrinolytic rhythme: with a simple method of measuring natural fibrinolysis. Clinical Science 16: 645.
    PubMedGoogle Scholar
  • 6 Fearnley G. R, Chakrabarty R. 1962; Increase of blood fibrinolytic activity by testosterone. The Lancet 02: 128.
    PubMedGoogle Scholar
  • 7 Fearnley G. R, Chakrabarty R, Avis P. R. D. 1963; Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and abesity. British Medical Journal 01: 921.
    CrossrefPubMedGoogle Scholar
  • 8 Gallimore M. J. 1967; Effect of diluents on blood clot lysis. Journal of Clinical Pathology 20: 234.
    CrossrefPubMedGoogle Scholar
  • 9 Genton E, Ross A. M, Takeda Y. A, Vogel J. H. K. 1970; Alterations in blood coagulation at high altitude. Advances in Cardiology 05: 32.
    PubMedGoogle Scholar
  • 10 MacFarlane R. G. 1937; Fibrinolysis following operation. The Lancet 01: 10.
    PubMedGoogle Scholar
  • 11 MacFarlane R. G, Pilling J. 1946; Observations on fibrinolysis, plasmin and antiplasmin content of human blood. The Lancet 02: 562.
    PubMedGoogle Scholar
  • 12 Marsh N. A, Vere D. W. 1967; A comparative account of standard and urinary urokinase. Clinica Chimica Acta 16: 389.
    CrossrefPubMedGoogle Scholar
  • 13 Mullertz S. 1956; Mechanism of activation and effect of plasmin in blood. Acta Physiologica Scandinavica 38 supplementum, 130.
    PubMedGoogle Scholar
  • 14 Singh I, Chohan I. S, Mathew N. T. 1969; Fibrinolytic activity in high altitude pulmonary oedema. Indian Journal of Medical Research 57: 210.
    PubMedGoogle Scholar
  • 15 Singh I, Chohan I. S. (1972a): Blood coagulation changes at high altitude predisposing to pulmonary hypertension. British Heart Journal 34: 611.
    PubMedGoogle Scholar
  • 16 Singh I, Chohan I. S. (1972b): Abnormalities in blood coagulation at high altitude. International Journal of Biometeorology 16: 283.
    PubMedGoogle Scholar
  • 17 Singh I, Chohan I. S. 1974; Adverse changes in fibrinolysis, blood coagulation and platelet functions in high altitude pulmonary oedema and their role in its pathogenesis. International Journal of Biometeorology 18: 33.
    CrossrefPubMedGoogle Scholar
  • 18 Singh I, Chohan I. S. 1973; Reversal of abnormal fibrinolytic activity, blood coagulation factors and platelet function in high altitude pulmonary oedema with Frusemide. International Journal of Biometeorology 17: 73.
    CrossrefPubMedGoogle Scholar